Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5568840

C1CNCCNCCNCCN1.Cl.Cl.Cl.Cl

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PDE4A known ✓ P27815 1/20 0.86
KDR known ✓ P35968 1/20 0.86
GAA known ✓ P10253 1/20 0.46
HIF1A Q16665 1/20 0.86
MAPT P10636 1/20 0.86
CXCR4 P61073 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
KDM4E B2RXH2 1/20 0.46
CYP2C9 P11712 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Piperazine SCHEMBL3062535 1.00 HIF1A (0.86) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL7690 1.00
Hydrochloric Acid SCHEMBL16226020 1.00 HIF1A (0.86) HIF1AMAPTPDE4AKDRCXCR4
Hydrochloric Acid SCHEMBL4769861 1.00 HIF1A (0.86) HIF1AMAPTPDE4AKDRCXCR4
Hydrochloric Acid SCHEMBL11801121 1.00 HIF1A (0.86) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL282455 1.00
Piperazine SCHEMBL20258219 1.00 HIF1A (0.86) HIF1AMAPTPDE4AKDRCXCR4
Hydrochloric Acid SCHEMBL11707528 1.00 HIF1A (0.86) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL6598522 1.00 HIF1A (0.86) HIF1AMAPTPDE4AKDRCXCR4
Piperazine SCHEMBL4467850 1.00

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4689165-A1 COMPOSITIONS AND METHODS FOR DNA LIBRARY PREPARATION ILLUMINA, INC. (US) 2026-02-11 EP claimed
US-20250369157-A1 COMPOSITIONS AND METHODS FOR DNA LIBRARY PREPARATION ILLUMINA INC (US) 2025-12-04 US claimed
US-20250197846-A1 TAGMENTATION WORKFLOW ILLUMINA, INC. 2025-06-19 US claimed
EP-4479553-A1 TAGMENTATION WORKFLOW ILLUMINA, INC. (US) 2024-12-25 EP claimed
CN-118974272-A Label fragmenting workflow 因美纳有限公司 2024-11-15 CN claimed
WO-2024206116-A1 COMPOSITIONS AND METHODS FOR DNA LIBRARY PREPARATION ILLUMINA, INC. (US) 2024-10-03 WO claimed
WO-2024023219-A1 TAGMENTATION WORKFLOW ILLUMINA CAMBRIDGE LIMITED (GB) 2024-02-01 WO claimed
CN-116759632-A Crown ether lithium salt compound and perovskite lithium battery thereof 美能能源技术(苏州)有限公司 2023-09-15 CN claimed
US-3930867-A MACROCYCLIC POLYAMINES AS SENSITIZERS FOR SILVER HALIDE EMULSIONS E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-01-06 US claimed
EP-4695390-A1 SOLID SUPPORT COMPRISING CYCLIC AMINE LIGANDS SUITABLE FOR POLYNUCLEIC ACID PROCESSING, ARTICLES AND METHODS Solventum Intellectual Properties Company (US) 2026-02-18 EP disclosed
EP-4689165-A1 COMPOSITIONS AND METHODS FOR DNA LIBRARY PREPARATION ILLUMINA, INC. (US) 2026-02-11 EP disclosed
US-20250369157-A1 COMPOSITIONS AND METHODS FOR DNA LIBRARY PREPARATION ILLUMINA INC (US) 2025-12-04 US disclosed
US-20250197846-A1 TAGMENTATION WORKFLOW ILLUMINA, INC. 2025-06-19 US disclosed
WO-2025121238-A1 METHOD FOR PRODUCING AROMATIC POLYSULFONE 住友化学株式会社 2025-06-12 WO disclosed
WO-1993024469-A1 PROCESS FOR PRODUCING N-β-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,7,10-TETRAAZACYCLODODECANE AND N-β-HYDROXYALKYL-TRI-N-CARBOXYALKYL-1,4,8,11-TETRAAZACYCLOTETRADECANE DERIVATIVES AND THEIR METAL COMPLEXES SCHERING AKTIENGESELLSCHAFT (DE) 1993-12-09 WO disclosed
EP-0558661-A1 POLYAZAMACROCYCLIC COMPOUNDS FOR COMPLEXATION OF METAL IONS. UNIV TEXAS (US) 1993-09-08 EP disclosed
WO-1993012097-A1 SYNTHESIS OF POLYAZAMACROCYCLES WITH MORE THAN ONE TYPE OF SIDE-CHAIN CHELATING GROUPS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-06-24 WO disclosed
US-5188816-A Using polyazamacrocyclic compounds for intracellular measurement of metal ions using MRS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1993-02-23 US disclosed
WO-1992008725-A1 POLYAZAMACROCYCLIC COMPOUNDS FOR COMPLEXATION OF METAL IONS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 1992-05-29 WO disclosed
EP-0481420-A1 Magnetic resonance imaging agent NIHON MEDI-PHYSICS CO., LTD. (JP) 1992-04-22 EP disclosed